Replies to post #119691 on Biotech Values

[mcbio]

ANDS—In what appears to be another instance of Zebra’s Law, ANDS is resuscitating ANA773, the TLR7 modulator for HCV that has been lying fallow for the past two years

The market seems to be finally catching on to the poor prospects for ANDS with market cap down to roughly $65M. Of course, I wouldn't touch it at this, or any, valuation.